Grunenthal has acquired the US-based pharmaceutical company Averitas Pharma, thereby extending its commercial footprint ...
Geneious Biologics, an enterprise software solution for companies engaged in screening of antibodies and antibody-like m...
Singapore – Amgen announced the final results from a five-year open-label study evaluating the abil...
Singapore – P-E player Veritas Capital and hedge fund Elliott Management have teamed to purchase Athenahealth...
According to a recent survey conducted by the World Health Organization (WHO), antibiotics are used far more in some cou...
Thermo Fisher Scientific Inc., the world leader in serving science, has elected Jim Mullen to its board of directors. Mu...
Jazz Pharmaceuticals plc announced that the National Institute for Health and Care Excellence (NICE) has publ...
AbbVie has announced patent license agreements with Momenta over its proposed biosimilar adalimumab product. Under the t...
Oncology Analytics, a leading technology-enabled service company which provides health plans, providers and patients wit...
A group of scientists from Rutgers University-New Brunswick Rutgers has created a tiny, biodegradable scaffold to transp...
Merck, the vibrant science and technology company, has launched its new BioContinuum Platform to advance biotherapeutic ...
Genetics can be used to predict a patient's response to antipsychotic drug treatment for schizophrenia, according to a r...
Singapore - In the future, cyberattackers may be able to exploit memory implants to steal, spy on, alter or control huma...
Pfizer recently announced that the U.S. Food and DrugAdministration (FDA) has aproved LORBRENA a third-generation ...
Amsterdam-based BioGX B.V., a subsidiary of Birmingham, Alabama based molecular diagnostics company BioGX, ann...
Agilent Technologies Inc. has introduced the Cary 3500 UV-Vis system, an innovative spectrophotometer designed to help l...
Sandoz, a Novartis division and the pioneer and global leader in biosimilars, has announced that the US Food and Drug Ad...
Singapore - The FDA approves a consumer-targeted molecular diagnostic test from privately held 23andme, t...
